In Vitro Evaluation of Commercially Available Theophylline Sustained Release Tablets in Pakistan

被引:0
|
作者
Ranjha, Nazar M. [1 ]
Mudassir, Jahanzeb [1 ]
Abbas, Tanveer [1 ]
Siam, Mohammad A. F. [1 ]
Hussain, Abid [1 ]
机构
[1] Bahauddin Zakariya Univ Multan, Fac Pharm, Dept Pharm, Multan, Pakistan
来源
LATIN AMERICAN JOURNAL OF PHARMACY | 2010年 / 29卷 / 06期
关键词
In vitro studies; Sustained release; Tablets; Theophylline; DRUG RELEASE; MATRICES; POLYMERS;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The dissolution behavior of five commercially available brands of sustained release theophylline tablets was studied in phosphate buffer solutions of pH 1.2, 4.5, 5.5, 6.0 and 7.5 at 37 degrees C using the USP dissolution apparatus H (paddle method). Drug concentration in the samples was determined spectrophotometrically at 272 nm. For predicting the release characteristics of theophylline from selected commercially available tablets the data obtained in the dissolution studies was fitted into various mathematic models defining kinetic parameters of drug release like zero-order rate equation, first-order rate equation, Hixen-crowell cube root law, Higuchi equation and Korsemeyer-Peppas model. Tablets were subjected to weight variation test, hardness, drug content and in vitro release studies. The present study revealed that drug release increases with the increase of pH of the dissolution medium and also varies from brand to brand. Among the five selected brands, B1 and B4 showed better pH dependency and drug release behaviour. It has been suggested that possible reasons for difference in dissolution or drug release behaviour are the difference in the manufacturing techniques and the quantity of hydrophobic excepients used by different manufacturers, which retard the penetration of dissolution medium and ultimately decreases availability of drug in the solution.
引用
收藏
页码:869 / 875
页数:7
相关论文
共 50 条
  • [1] Preparation and evaluation of theophylline sustained-release tablets
    Meshali, MM
    ElSayed, GM
    ElSaid, Y
    ElAleem, HMA
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1996, 22 (04) : 373 - 376
  • [2] INVITRO DISSOLUTION OF SOME COMMERCIALLY AVAILABLE SUSTAINED-RELEASE THEOPHYLLINE PREPARATIONS
    BUCKTON, G
    GANDERTON, D
    SHAH, R
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1988, 42 (1-3) : 35 - 39
  • [3] SUSTAINED-RELEASE TABLETS OF THEOPHYLLINE
    SANGHAVI, NM
    KAMATH, PR
    AMIN, DS
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1990, 16 (11) : 1843 - 1848
  • [4] In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets
    Hayashi, Tetsuo
    Kanbe, Hideyoshi
    Okada, Minoru
    Kawase, Ichiro
    Ikeda, Yasuo
    Onuki, Yoichi
    Kaneko, Tetsuo
    Sonobe, Takashi
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 341 (1-2) : 105 - 113
  • [5] Excipient-excipient interaction in the design of sustained-release theophylline tablets: In vitro and in vivo evaluation
    Bayomi, MA
    Al-Suwayeh, SA
    El-Helw, ARM
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2001, 27 (06) : 499 - 506
  • [6] THE BIOAVAILABILITY OF THEOPHYLLINE SUSTAINED-RELEASE TABLETS
    BARRETT, WE
    HANIGAN, JJ
    SNYDER, DL
    [J]. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1981, 30 (03): : 335 - 350
  • [7] ABSORPTION OF SUSTAINED-RELEASE THEOPHYLLINE TABLETS
    FAGERSTROM, PO
    HEINTZ, L
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1983, 21 (07) : 359 - 362
  • [8] DESIGN AND IN VITRO EVALUATION OF SUSTAINED RELEASE TABLETS OF RANOLAZINE
    Priya, M. Ranga
    Natarajan, R.
    Rajendran, N. N.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2011, 2 (04): : 922 - 928
  • [9] COMPARITIVE IN VITRO EVALUATION OF DIFFERENT COMMERCIALLY AVAILABLE BRANDS OF PANTOPRAZOLE TABLETS
    Rani, T. Neelima
    Kumari, Ch. T. Lalitha
    Reddy, B. Mallikarjun
    Reddy, D. R. Brahma
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2012, 3 (04): : 1108 - 1111
  • [10] CHARACTERIZATION OF COMMERCIALLY AVAILABLE THEOPHYLLINE SUSTAINED-RELEASE OR CONTROLLED-RELEASE SYSTEMS - INVITRO DRUG RELEASE PROFILES
    PO, ALW
    WONG, LP
    GILLIGAN, CA
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1990, 66 (1-3) : 111 - 130